Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · STATUTE-COMPILATIONS · National Defense Authorization Act for Fiscal Year 2024 · Sec. 725

Sec. 725. STUDY AND REPORT ON HEALTH CONDITIONS OF MEMBERS OF THE ARMED FORCES ON ACTIVE DUTY DEVELOPED AFTER ADMINISTRATION OF COVID-19 VACCINE

283 words·~1 min read·/statute-compilations/comps-17632/sec-725

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 725 STUDY AND REPORT ON HEALTH CONDITIONS OF MEMBERS OF THE ARMED FORCES ON ACTIVE DUTY DEVELOPED AFTER ADMINISTRATION OF COVID-19 VACCINE ###
(a)Study The Secretary of Defense shall conduct a study to assess and evaluate any health conditions arising in members of the Armed Forces on active duty one year after receiving the first dose of a COVID-19 vaccine. ###
(b)Study Parameters In conducting the study under subsection (a), the Secretary shall— ####
(1)disaggregate data collected by— #####
(A)vaccine type and manufacturer; #####
(B)age group at the time such first dose was administered; #####
(C)any health condition developed after receiving such first dose, regardless of whether the condition is attributable to the receipt of such first dose; and #####
(D)an accounting of adverse events (including hyperimmune response), including further disaggregation by history of infection; and ####
(2)assess the prevalence of each such health condition by each age group specified in paragraph (1)(B) among the unvaccinated population for each of years 2017, 2018, and 2019. ###
(c)Report Not later than one year after the date of the enactment of this Act and each year thereafter for the subsequent four years, the Secretary shall submit to the Committees on Armed Services of the House of Representatives and the Senate a report on the results of each study conducted under subsection (a). ###
(d)COVID-19 Vaccine Defined The term “COVID-19 vaccine” means a vaccine licensed under section 351 of the Public Health Service Act (42 U.S.C. 262) or authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb-3) for immunization against the virus responsible for COVID-19.
Connectionstraces to 2
Citation graph
cites case law
Sec. 725
STUDY AND REPORT ON HEALTH CONDITIONS OF MEMBERS OF THE ARMED FORCES ON ACTIVE DUTY DEVELOPED AFTER ADMINISTRATION OF COVID-19 VACCINE
Cites 2Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.